FundedIQ
Health Care

NanoVibronix: Funding, Investors & Team (Sep 2026)

NanoVibronix is a medical device company that specializes in creating medical products using its unique low-intensity acoustic technology. The company's patented technology allows for the production of small transducers that can transmit low-frequency ultrasound through flexible surfaces. This innovation has a wide range of potential medical applications and is cost-effective. Their products, including PainShieldTM and WoundShieldTM, have received CE Mark certification, and PainShield also has FDA clearance. NanoVibronix's catheter-based products, such as UroShieldTM and NG-ShieldTM, are also CE mark certified. The company is based in Melville, New York, with a subsidiary in Nesher, Israel.

www.nanovibronix.com LinkedIn Melville, United States 1-10 employees
Health Care Medical Device Therapeutics
Total raised
$21.3M
Rounds
3
Latest
Undisclosed round
Jul 2025

NanoVibronix has raised $21.3M across 3 funding rounds on record, the most recent an undisclosed round of $8.9M announced in Jul 2025.

That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.

NanoVibronix Company Profile and Key Stats

Total funding raised
$21.3M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$8.9M in Jul 2025
Employees
1-10
reported band
Headquarters
Melville, United States

Latest funding round on record: Jul 2025.

NanoVibronix Funding Rounds

Date
Round
Amount
Undisclosed round
$8.9M
Undisclosed round
$10.0M
Undisclosed round
$2.4M

NanoVibronix raised $2.4M in an undisclosed round announced in Dec 2022.

2.4 years later, an undisclosed round of $10.0M was announced in May 2025.

2 months later, an undisclosed round of $8.9M was announced in Jul 2025.

NanoVibronix Founders and Leadership Team

Name
Role
Contact
Harold Jacob
Founder

No contact details are on record for this team yet.

NanoVibronix Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.7M
29,722
$7.5M

NanoVibronix's latest round of $8.9M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like NanoVibronix in Health Care and Melville

Companies Similar to NanoVibronix

https://metriport.com

Series A $26.0M

There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…

Series A $17.0M

Serif Health provides healthcare price intelligence and contract management solution.

Private Equity $5.7M

Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…

Undisclosed round $5.0M

Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…

Seed $750k

TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…

Series A $10.0M

Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.

Undisclosed round $1.5M

Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…

Undisclosed round $3.0M

Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…

Series A $14.0M

Happy Health is a mission-driven technology company committed to transforming mental health awareness through…

Undisclosed round $75.0M

Leal Therapeutics creates new treatments for patients.

Series A $30.0M

Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…

Series A $18.3M

NanoVibronix Funding FAQs

What does NanoVibronix do?

NanoVibronix is a medical device company that specializes in creating medical products using its unique low-intensity acoustic technology. The company's patented technology allows for the production of small transducers that can transmit low-frequency ultrasound through flexible surfaces. This innovation has a wide range of potential medical applications and is cost-effective. Their products, including PainShieldTM and WoundShieldTM, have received CE Mark certification, and PainShield also has FDA clearance. NanoVibronix's catheter-based products, such as UroShieldTM and NG-ShieldTM, are also CE mark certified. The company is based in Melville, New York, with a subsidiary in Nesher, Israel.

How much funding has NanoVibronix raised?

NanoVibronix has raised $21.3M across 3 rounds on record. The most recent is an undisclosed round of $8.9M announced in Jul 2025.

When did NanoVibronix last raise funding?

NanoVibronix's most recent funding round on record is an undisclosed round of $8.9M, announced in Jul 2025.

Who founded NanoVibronix?

FundedIQ lists Harold Jacob (Founder) at NanoVibronix.

Where is NanoVibronix headquartered?

NanoVibronix is based in Melville, New York, United States.

How many employees does NanoVibronix have?

NanoVibronix is in the 1-10 employee band.

How does NanoVibronix's funding compare to other Health Care startups?

NanoVibronix's latest round of $8.9M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's NanoVibronix Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NanoVibronix is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.